language
Language
Englishchevron_right
attach_money
Currency
$USDchevron_right
dark_mode
Dark Mode
policy
Privacy Policy
gavel
Terms of Service
SYSY

$3.76

-0.53
arrow_drop_down12.35%
Current Market·update12 Nov 2025 21:00

$3.89

+0.13
arrow_drop_up3.46%
Pre-market·update13 Nov 2025 11:45
Day's Range
3.7501-4.41
52-week Range
0.673-6.28

Chart

Loading chart...

Performance

Key Stats

Next Earnings Date2025-11-17
Next Earnings TimeBefore Market Open
Volume2M
Average Volume 30d1.37M

AI SY Summary

Powered by LiveAI
💰
-0.7
Valuation (P/E Ratio)
Negative P/E due to net loss, consider PS ratio.
📈
-1.18
Revenue Growth (YoY)
Revenue decreased year-over-year.
Show More 🔒

AI Scoreboard

Powered by LiveAI
🔒

Overall Analysis

Neutral
65

So-Young International Inc. exhibits mixed signals. While there are some positive fundamental indicators like revenue growth and a strong cash position, the company has been unprofitable recently. Technicals suggest a downtrend, and thematic factors related to its specific market niche need careful consideration. It is currently trading at a price point that reflects significant past growth, but its future trajectory is uncertain.

Neutral

Thematic

50

So-Young operates in the consumption healthcare and medical aesthetics market in China. This sector can be influenced by consumer spending, regulatory changes, and evolving trends in beauty and wellness. While there's potential for growth, it's a niche market with specific demographic and economic dependencies.

Neutral

Fundamental

60

So-Young demonstrates strong revenue growth in its latest reported periods, supported by a healthy balance sheet with significant cash equivalents. However, the company is currently unprofitable, with negative net income and EPS. The valuation metrics are mixed, with a negative P/E ratio due to unprofitability, but a positive Price-to-Sales ratio.

Neutral

Technical

50

The stock's current price (4.58) is near its 52-week low (0.664) but significantly below its 52-week high (6.28). Performance metrics show a strong recent surge (6M: 450%, YTD: 477%, 1Y: 385%), which is contradicted by the current price drop of -3.17%. Technical indicators across various timeframes (1m to 1d) largely suggest 'Sell' or 'Neutral' for moving averages and oscillators, indicating a potential downtrend or consolidation.

FactorScore
Medical Aesthetics Market Growth70
Online Platform Dominance60
Consumer Spending Sensitivity40
Regulatory Landscape in China45
Competition from other platforms/providers50
FactorScore
Valuation65
Profitability20
Growth40
Balance Sheet Health85
Cash Flow30
FactorScore
Trend Analysis30
Momentum55
Volume Trends50
Support and Resistance50
Short-term Oscillators45

AI Investing Checklist

Powered by LiveAI
thumb_up

Bullish Points (6)

Performance chevron_right

Exceptional Short-Term Performance

The stock has experienced significant positive performance over shorter periods, with a 1-month return of 93.25% and a Year-to-Date (YTD) return of 477.67%, indicating strong recent investor interest and potential momentum.

Key Statistics chevron_right

Substantial Market Capitalization and Liquidity

The company has a market capitalization of $459.01 million and an average daily trading volume of 2.96 million shares, suggesting good liquidity and a sizable presence in the market.

Show More 🔒
thumb_down

Bearish Points (8)

Current Price chevron_right

Recent Price Decline

The stock price has recently decreased by 3.17% to $4.58, and the daily range indicates volatility, with the current price below the 52-week high.

Earnings Performance chevron_right

Negative Earnings Per Share (EPS) and Net Income

The company has consistently reported negative EPS (e.g., -0.81 TTM) and negative net income (e.g., -$589.53 million in 2024), indicating a lack of profitability.

Show More 🔒

Calendar

April 2025

8

Ex-Dividend Date

April 2025

25

Next Dividend Date

August 2025

21

Next Earnings Date

EPS Est.
Revenue Est.

H: $-0.11

A: $-0.11

L: $-0.11

H: 362.23M

A: 362.23M

L: 362.23M

Profile

Employees (FY)1.8K
ISINUS83356Q1085
FIGI-

So-Young International Inc. operates an online platform for consumption healthcare services in the People's Republic of China. The company offers So-Young Mobile App that offers users access to medical aesthetic knowledge, community support and reservation options for treatment with medical professionals, and medical aesthetic institutions; Weixin mini program to explore treatment options, check prices, schedule appointments, participate in online consultations, and track follow-ups; and medical aesthetic community content through its website soyoung.com. Its aesthetic centers offer non-invasive and minimally invasive procedures, including device-based options, such as thread lifts, intense pulsed light, ultrasound facelifts, picosecond lasers, and body contouring treatments, as well as injectable treatments, including skin boosters, hyaluronic acid-based products, botox, and type I and type III collagen. In addition, the company engages in the research and development, production, sale, and distribution of light therapy devices, including excimer laser systems, UV excimer therapy devices, LED and red-light therapy systems, and advanced laser and intense pulsed light technologies; surgical laser devices, including carbon dioxide laser machines, multi-wavelength and semiconductor laser systems, and hydrodynamic-assisted liposuction systems, as well as pneumatic liquid spray devices. Further, it offers injectable products; sales and technical, maintenance, installation, operational training, error reporting, maintenance, and equipment packaging services; consumption healthcare services, including dermatology, dentistry and orthodontics, physical examinations, gynecology, and postnatal care; reservation services; and content management through beauty diaries, short-form videos, treatment reviews, featured articles, and chat messages. The company was founded in 2013 and is headquartered in Chaoyang, China.

Seasonals

2025
2024
2023
2022
2021

Price Target

5.71 USD

The 39 analysts offering 1 year price forecasts for SY have a max estimate of 10.11 and a min estimate of 1.51.

Debt Level and Coverage

Debt
Free cash flow
Cash & equivalents

Financial Position Analysis

Assets
Liabilities

Ownership

Free Float shares
36.1M (42.70%)
Closely held shares
48.5M (57.30%)
84.6M
Free Float shares
36.1M (42.70%)
Closely held shares
48.5M (57.30%)

Capital Structure

Market cap
387.56M
Debt
239.88M
Minority interest
0.00
Cash & equivalents
587.75M
Enterprise value
39.69M

Valuation - Summary

Market Cap
459M
Net income
-620M(-135.15%)
Revenue
1.04B(226.20%)
459M
Market Cap
459M
Net income
-620M(-135.15%)
Revenue
1.04B(226.20%)
Price to earning ratio (P/E)-0.70x
Price to sales ratio (P/S)0.40x

Valuation - Ratios

P/E
P/S

Revenue to Profit Conversion

Revenue
1.47B
COGS
567.59M
Gross Profit
899.11M
OpEx
983.6M
Operating Income
-84.48M
Other & Taxes
505.04M
Net Income
-589.53M

Balance Sheet

Total assets
Total liabilities
Liabilities to assets %

Income Statement

Revenue
Net Income
Net Margin

Cash Flow

Operating Cash Flow
Investing Cash Flow
Financing Cash Flow
Show More 🔒